Virtual West Oncology Conference
Playback speed
10 seconds
ASH Updates on MDS: Is Luspatercept Affecting Biomarkers of Erythropoiesis in LR-IR Disease? Is EFS Better With Pevonedistat+Aza vs. Aza Alone in HR-MDS? Should We Combine Ven+Aza?
By
Virtual West Oncology Conference
FEATURING
Jason Chandler
By
Virtual West Oncology Conference
FEATURING
Jason Chandler
125 views
March 11, 2021
Comments 0
Login to view comments.
Click here to Login
Videos